News
On a special episode (first released on July 16, 2025) of The Excerpt podcast: Despite the banning of hashtags that promote unhealthy weight loss content, the influence of SkinnyTok and thinspo ...
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...
New and improved, it’s the app that makes your membership truly mobile! Help Register Login Login Hi, %{firstName}% Hi, ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
I fear marriage, and I fear becoming a mother. Watching what my mum went through…I just don’t want to go through that.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results